参考文献/References:
[1] Mcvary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia[J]. J Urol, 2011, 185(5): 1793-1803.
[2]袁渊 ,姚启盛 ,王晓康 ,等.高龄前列腺增生患者合并心血管疾病的围手术期处理[J/CD]. 中华腔镜泌尿外科杂志: 电子版,2013, 7(1): 25-28.
[3] 王荣, 范明, 章小平. 经尿道前列腺中叶剜除术治疗高危前列腺中叶增生[J/CD]. 中华腔镜泌尿外科杂志: 电子版, 2013, 6(1):39-43.
[4] 赵军, 张宁, 胡岚亭, 等. 高龄高危患者经尿道前列腺气化电切术疗效分析[J]. 中国内镜杂志, 2012, 18(7): 734-737.
[5] 李钢, 夏克勤, 邓建松, 等. 坦索罗辛与非那雄胺联用治疗对前列腺增生症[J]. 药物流行病学杂志, 2009, 18(5): 324-326.
[6] 蒋晓璇. 盐酸坦索罗辛与非那雄胺联合治疗前列腺增生症临床观察[J]. 中国误诊学杂志, 2011, 11(25): 6091-6091.
[7] 夏媛, 甄鹏. 良性前列腺增生的药物治疗与监护[J]. 中国医药指南, 2014, 12(5): 41-42.
[8] Zhu YS, Imperato-Mcginley JL. 5alpha-reductase isozymes and androgen actions in the prostate [J]. Ann N Y Acad Sci, 2009,1155: 43-56.
[9] Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia[J]. World J Urol, 2002, 19(6): 413-425.
[10] Greco KA, Mcvary KT. The role of combination medical therapy in benign prostatic hyperplasia [J]. Int J Impot Res, 2008, 20 Suppl3: S33-S43.
[11] 丁留成, 卫中庆, 沈百欣, 等. 坦索罗辛在晚期前列腺癌伴膀胱出口梗阻中的应用价值[J/CD]. 中华临床医师杂志: 电子版,2012, 6(13): 28-30.
[12] Roehrborn CG. The clinical benefits of dutasteride treatment for LUTS and BPH[J]. Rev Urol, 2004, 6(Suppl 9): S22-S30.
[13] 葛华, 尚攀峰, 杨瑞芳, 等. 盐酸坦索罗辛治疗不同体积BPH 的疗效及安全性评价[J]. 临床泌尿外科杂志, 2011, 26(3): 239-240.
[14] 张元芳, 叶烈夫, 丁强, 等. 不同前列腺组织中睾酮及双氢睾酮含量测定的研究[J]. 中华外科杂志, 2000, 38(7): 545-547.
[15] Partin AW, Rodriguez R. The molecular biology, Endocrinology, and Physiology of the Prostate and Seminal Vesicles. In: Walsh PC, ed. Campbell’s Urology [M]. 8th, ed. Philadelphia: Elsevier science, 2002: 1235-1296.
相似文献/References:
[1]邓立文,涂响安,邓春华.经尿道前列腺电切术后谵妄诊治的临床分析[J].中华腔镜泌尿外科杂志(电子版),2008,(02):118.
DENG Li-wen,TU Xian-gan,DENG Chun-hua.Clinical analysis of postoperative delirium in transurethral resection of the prostate[J].,2008,(01):118.
[2]王亮,李黎明,崔喆,等.经尿道前列腺等离子双极电切术与普通电切术中失血量比较[J].中华腔镜泌尿外科杂志(电子版),2009,(01):11.
WANG Liang,LI Li-ming,CUI Zhe,et al.Blood loss comparison of transurethral plasmakinetic resection versus conventional transurethral resection of the prostate[J].,2009,(01):11.
[3]杨德林,柯昌兴,王剑松,等.等离子电切术中不同方法治疗前列腺增生症(附1900例报告)[J].中华腔镜泌尿外科杂志(电子版),2009,(01):37.
YANG De-lin,KE Chang-xing,WANG Jian-song,et al.Various methods of transurethral plasmakinetic resection of prostate for the treatment of BPH ( Report of 1900 cases)[J].,2009,(01):37.
[4]何志新,温天奋,彭晓东,等.经尿道前列腺汽化电切术治疗前列腺增生症[J].中华腔镜泌尿外科杂志(电子版),2009,(04):309.
[5]李方,徐友明,刘进,等.膀胱颈切开防止小体积前列腺汽化电切术后膀胱颈挛缩的回顾研究[J].中华腔镜泌尿外科杂志(电子版),2009,(06):508.
LI Fang,XU You-ming,LIU Jin,et al.Compare the contracture of the bladder neck after TUVP with bladder neck incision or not in patients with small prostate: a retrospective study[J].,2009,(01):508.
[6]杨志国,赵海东,刘永江,等.急诊经尿道前列腺电切治疗良性前列腺增生并急性尿潴留[J].中华腔镜泌尿外科杂志(电子版),2010,(01):46.
YANG Zhi-guo,ZHAO Hai-dong,LIU Yong-jiang,et al.Transurethral resection of the prostate as emergency surgery for the treatment of BPH with acute urinary retention[J].,2010,(01):46.
[7]宋金亮,张斌.经尿道前列腺等离子电切术治疗合并糖尿病的良性前列腺增生症[J].中华腔镜泌尿外科杂志(电子版),2010,(01):69.
[8]王玉亭,李金海.前列腺汽化电切术后出血原因及治疗对策分析[J].中华腔镜泌尿外科杂志(电子版),2010,(03):204.
WANG Yu-ting,LI Jin-hai.Analysis of the reasons and treatments of bleeding after tranurethral vaporization of the prostate[J].,2010,(01):204.
[9]彭明栋,陈永生,陈云峰,等.经尿道双极等离子体电切治疗高危前列腺增生症:附200例报告[J].中华腔镜泌尿外科杂志(电子版),2010,(03):211.
PENG Ming-dong,CHEN Yong-sheng,CHEN Yun-feng,et al.Bipolar plasma kinetic resection of the prostate for the treatment of benign prostatic hyperplasia in the patients with high risk: a report of 200 cases[J].,2010,(01):211.
[10]程书栋,王慕华,王建文,等.经尿道双极等离子前列腺腔内剜除术治疗前列腺增生220例临床疗效分析[J].中华腔镜泌尿外科杂志(电子版),2010,(05):380.
CHEN Shu-dong,WANG Mu-hua,WANG Jian-wen,et al.Bipolar plasmakinetic transurethral enucleation of prostate in the treatment of benign prostatic hyperplasia: Report of 220 cases[J].,2010,(01):380.
[11]江东 郭振宇 麦蕾 冯旭升 郭德荣.围手术期应用度他雄胺对经尿道前列腺等离子切除术出血量的影响[J].中华腔镜泌尿外科杂志(电子版),2014,(05):366.[doi:10.3877/cma.j.issn.1674-3253.2014.05.013
]
Jiang Dong,Guo Zhenyu,Mai Lei,et al.The effect on bleeding volume of transurethral plasmakinetic prostatectomy by perioperative use of dutasteride[J].,2014,(01):366.[doi:10.3877/cma.j.issn.1674-3253.2014.05.013
]